当前位置: 首页 > 详情页

CD133 positive U87 glioblastoma cells-derived exosomal microRNAs in hypoxia- versus normoxia-microenviroment

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, China Natl Clin Res Ctr Neurol Dis NCRC ND, Beijing Key Lab Brain Tumor,Ctr Brain Tumor,Dept, Beijing Inst Brain Disorders,Beijing Tiantan Hosp, Tiantan Xili 6, Beijing 100050, Peoples R China; [2]Capital Med Univ, Beijing Neurosurg Inst, Beijing Tiantan Hosp, Dept Neurosurg,Brain Tumor Res Ctr, Tiantan Xili 6, Beijing 100050, Peoples R China
出处:
ISSN:

关键词: Exosome Glioblastoma Hypoxia Normoxia MicroRNA

摘要:
Hypoxia is a major regulator of glioma development and aggressiveness. However, how CD133 positive U87 glioblastoma cells adapt to hypoxia and communicate with their surrounding microenvironment during tumor development remain important questions. Communication with host cells and stroma via exosomes represents one pathway by which tumors can modify their surroundings to achieve a tumor-permissive environment. MicroRNAs are thought to be essential actors of tumorigenesis as they are able to control the expression of numerous genes. Here, we show that exosomes derived from CD133+ U87 glioblastoma cells grown at hypoxic compared with normoxic conditions are potent proliferation inducers of the tumor vasculature and glioma cells proliferation in vitro. Moreover, we analyze the microRNA content of exosomes produced in vitro by hypoxia and normoxia CD133+ U87 glioblastoma cells using Affymetrix microarrays. It appears that the exosome microRNA profiles are qualitatively quite similar. Nevertheless, their quantitative profiles are different and may be potentially taken as an opportunity to carry out assays of diagnostic interest. We conclude that CD133+ U87 glioblastoma cells derived exosome-mediated miRNA transduction play an important role of mediating a proangiogenic response and glioma cells proliferation, and that the exosomal pathway constitutes a potentially targetable driver of hypoxia-dependent intercellular signaling during tumor development.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 3 区 医学
小类 | 3 区 临床神经病学 3 区 肿瘤学
最新[2023]版:
大类 | 2 区 医学
小类 | 3 区 临床神经病学 3 区 肿瘤学
JCR分区:
出版当年[2015]版:
Q2 CLINICAL NEUROLOGY Q3 ONCOLOGY
最新[2023]版:
Q2 CLINICAL NEUROLOGY Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Capital Med Univ, China Natl Clin Res Ctr Neurol Dis NCRC ND, Beijing Key Lab Brain Tumor,Ctr Brain Tumor,Dept, Beijing Inst Brain Disorders,Beijing Tiantan Hosp, Tiantan Xili 6, Beijing 100050, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, China Natl Clin Res Ctr Neurol Dis NCRC ND, Beijing Key Lab Brain Tumor,Ctr Brain Tumor,Dept, Beijing Inst Brain Disorders,Beijing Tiantan Hosp, Tiantan Xili 6, Beijing 100050, Peoples R China; [2]Capital Med Univ, Beijing Neurosurg Inst, Beijing Tiantan Hosp, Dept Neurosurg,Brain Tumor Res Ctr, Tiantan Xili 6, Beijing 100050, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院